- Home
- ENLT vs STAA Comparison
ENLT vs STAA Comparison
Compare ENLT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLT | STAA |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Ophthalmic Goods |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 1.1B |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ENLT | STAA |
|---|---|---|
| Price | $75.03 | $20.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $48.83 | $22.81 |
| AVG Volume (30 Days) | 141.6K | ★ 737.1K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $403.69 | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ $76.10 | $81.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.05 | $15.59 |
| 52 Week High | $108.65 | $35.87 |
Technical Indicators
Market Signals| Indicator | ENLT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 32.30 |
| Support Level | $74.52 | $19.82 |
| Resistance Level | $79.81 | $26.21 |
| Average True Range (ATR) | 1.63 | 1.01 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 55.56 | 7.19 |
Price Performance
Historical ComparisonAbout ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.